bioRxivCancer Biology
EphB6 regulates TFEB-lysosomal pathway and survival of disseminated indolent breast cancer cells
M. Zangrossi, P. Chakravarty, P. Romani, C. D. H. Ratcliffe, S. Hooper, M. Dori, M. Forcato, S. Bicciato, S. Dupont, E. Sahai, M. MONTAGNER
Abstract
Late relapse of disseminated cancer cells is a common feature of some types of tumors. Several intrinsic and extrinsic factors have been shown to affect reawakening of disseminated dormant cancer cells (DDCCs); however, the signals and processes sustaining survival of DDCCs in a foreign environment are still poorly understood. We have recently shown that crosstalk with lung epithelial cells promotes persistence of DDCCs from estrogen receptor positive (ER+) breast tumors. Here we show that TFEB-lysosomal axis is activated in DDCCs and that it is modulated by the pro-survival ephrin receptor EphB6. TFEB lysosomal direct targets are enriched in DDCCs in vivo and correlate with relapse in ER+ breast cancer patients. Direct contact of DDCCs with alveolar type I-like lung epithelial cells drives lysosomal accumulation and EphB6 induction. EphB6 contributes to TFEB transcriptional activity and lysosome formation in DDCCs in vitro and in vivo, and supports survival of DDCCs in coculture and in vivo. Furthermore, signaling from EphB6 promotes the proliferative response of surrounding lung parenchymal cells in vivo.
- organism: human
- assay: bulk RNA-seq
- research focus: cell signaling & trafficking
- research focus: cancer & tumor microenvironment
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells
E. R. Sheidemann, D. M. Demas, … A. N. Shajahan-Haq·bioRxiv·Apr 17, 2023
- Epithelial-mesenchymal plasticity determines estrogen receptor positive (ER+) breast cancer dormancy and reacquisition of an epithelial state drives awakening
A. Patrik, Z. Yueyun, … C. Brisken·bioRxiv·Jul 22, 2021
- The breast tumor microenvironment exploits eosinophil plasticity to suppress their anti-tumor activity
Zofia Varyova, Mathilde Pohin, … Kim S. Midwood·bioRxiv·Jan 12, 2026
- Pharmacological CDK4/6 inhibitors promote senescence-associated lysosomal alterations and enhance sensitivity to lysosomotropic agents in breast cancer
Jamil Nehme, Sjors Maassen, … Marco Demaria·The EMBO JournalPeer-reviewed·Feb 10, 2025
- Pericyte-tumor crosstalk facilitates metastatic tumor cell latency through PIEZO1-activated lysophospholipid transfer.
Tamara McErlain, Morgan J. Glass, … Meera Murgai·bioRxiv·Feb 15, 2025
- Malignant epithelial diversification and inflammatory neutrophil remodeling define a transitional stage between tumor cell dissemination and overt metastatic outgrowth in breast cancer
Rajneesh Pathania, Brian N. Papas, … Raja Jothi·bioRxiv·Aug 26, 2026